A Phase 2 trial evaluating doses as low as 1 mg demonstrated measurable improvements in HbA1c levels and body weight, with fewer gastrointestinal side effects compared to higher doses, suggesting that starting with microdoses may enhance tolerability
Tirzepatide trials showed rates around 12-27% depending on the dose
Knowing this connection helps you better prepare for and manage this side effect during your treatment journey
A dedicated single-injection 7.2 mg pen is expected later in 2026
With so many people using GLP-1 medications for weight loss, one question remains: do you need to pay out of pocket, or does insurance cover GLP-1 medications
AstraZeneca PLC is a biopharmaceutical company that researches, develops, manufactures, and sells prescription drugs